How Advances in T-Cell Receptor Profiling Can Boost Early Cancer Diagnosis
New developments in flow cytometry and molecular biology promise to improve the detection of rare cancers
Diagnostic Testing and Emerging Technologies
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
Diagnostics Pipeline: Savara Introduces Blood Test to Detect aPAP, a Rare Lung Disorder
Savara’s ClearPath assay needs just a few drops of blood to test for aPAP, a condition that can be difficult and invasive to diagnose
Success of Digital Pathology May Come Through its Ability to Handle Volumes
Digital and computational pathology expert Donal O’Shea explores the role of emerging technologies in addressing workforce shortages
Image-Based AI Touted as a New Weapon Against Rare Cancers
Studies by Paige demonstrate the greater accuracy that artificial intelligence potentially offers for pathologists
Are We in a ‘Quademic’? COVID-19, Flu, RSV, and Norovirus Infections Surge
The pandemic may have set the stage for a jump in infections from these four nemeses
Bringing Clinical Mass Spectrometry into Routine Medical Laboratory Testing
Roche experts discuss the company’s recently launched automated solution and how it will bring mass spec to more patients
Diagnostics Pipeline: Roche’s New Cobas Liat Panel Can Test for Multiple STIs Simultaneously
The PCR-driven test provides results in about 20 minutes in non-laboratory settings
Labcorp, Quest, and ARUP Develop Bird Flu Tests with CDC Help
The assays were developed with the CDC as part of recent trend of public-private partnerships to improve pandemic preparedness
Implementing Accessible On-Demand Testing: A Lab Director’s Experience
On-demand testing doesn’t require registration, billing, or scheduling, keeping costs low while collecting “real” dollars upfront
Patients at the Point of Care
At-home testing is giving patients an increasingly active role in managing their health—but what does this trend mean for labs?
Choosing and Using Wisely
The value of lab test utilization management—and the ASCP’s latest best practice recommendations for effective test utilization
Assessing At-Home Testing Accuracy
Patients desire direct-to-consumer testing, but are the results this testing provides accurate and reliable?
Diagnostics Pipeline: 2024 Trends in FDA Approvals
In vitro diagnostic products approved by the U.S. Food and Drug Administration in 2024 show a continued move toward rapid and point-of-care tests
